| 2025-04-16 18:10 | CC:BCT | Briacell Therapeutics Corp (3) | 6.17 | News Release200 | Briacell releases survival data for Bria-IMT patients |
| 2025-04-10 17:03 | CC:BCT | Briacell Therapeutics Corp (3) | 5.71 | News Release200 | Briacell's BriaPro developing antibodies to B7-H3 |
| 2025-03-26 08:00 | CC:BCT | BRIACELL THERAPEUTICS CORP. J | 5.81 | News Release200 | BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference |
| 2025-03-20 18:00 | CC:BCT | Briacell Therapeutics Corp (3) | 6.39 | News Release200 | Briacell gets DSMB recommendation to continue phase 3 |
| 2025-03-12 17:32 | CC:BCT | Briacell Therapeutics Corp (3) | 5.10 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-03-12 17:27 | CC:BCT | Briacell Therapeutics Corp (3) | 5.10 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-02-05 19:23 | CC:BCT | Briacell Therapeutics Corp (3) | 6.48 | News Release200 | Briacell shareholders approve AGM resolutions |
| 2025-02-05 18:50 | CC:BCT | Briacell Therapeutics Corp (3) | 6.48 | News Release200 | Briacell Therapeutics closes $3.05-million financing |
| 2025-02-03 20:52 | CC:BCT | Briacell Therapeutics Corp (3) | 7.30 | News Release200 | Briacell arranges public offering |
| 2025-02-03 19:59 | CC:BCT | BRIACELL THERAPEUTICS CORP. J | 7.30 | News Release200 | BriaCell Therapeutics Announces Pricing of Public Offering |
| 2025-02-03 17:21 | CC:BCT | Briacell Therapeutics Corp (3) | 7.30 | News Release200 | Briacell data show "resolution" of lung metastasis |
| 2025-01-27 19:56 | CC:BCT | Briacell Therapeutics Corp (2) | 0.54 | News Release200 | Briacell completes 1:15 share rollback |
| 2025-01-24 21:11 | CC:BCT | Briacell Therapeutics Corp (2) | 0.57 | Rollback291 | Briacell Therapeutics 1:15 rollback |
| 2025-01-03 17:20 | CC:BCT | Briacell Therapeutics Corp (2) | 0.93 | News Release200 | Briacell okays 1:15 rollback effective Jan. 24 |
| 2025-01-03 17:20 | CC:BCT | Briacell Therapeutics Corp (2) | 0.93 | News Release200 | Briacell Therapeutics reschedules AGM to Feb. 5 |
| 2024-12-17 19:50 | CC:BCT | Briacell Therapeutics Corp (2) | 0.91 | News Release200 | Briacell Therapeutics files AGM materials on-line |
| 2024-12-17 16:05 | CC:BCT | BRIACELL THERAPEUTICS CORP. J | 0.89 | News Release200 | BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures |
| 2024-12-16 17:38 | CC:BCT | Briacell Therapeutics Corp (2) | 0.89 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-12-16 17:31 | CC:BCT | Briacell Therapeutics Corp (2) | 0.89 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-12-13 17:39 | CC:BCT | Briacell Therapeutics Corp (2) | 0.95 | News Release200 | Briacell closes $5.5-million public offering |
| 2024-12-13 07:50 | CC:BCT | BRIACELL THERAPEUTICS CORP. J | 0.95 | News Release200 | BriaCell 2024 SABCS(TM) Poster Highlights Ability of Bria-IMT(TM) Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer |
| 2024-12-12 09:05 | CC:BCT | Briacell Therapeutics Corp (2) | 1.59 | News Release200 | Briacell Therapeutics prices $5.55-million financing |
| 2024-12-11 19:57 | CC:BCT | Briacell Therapeutics Corp (2) | 1.59 | News Release200 | Briacell Therapeutics arranges public offering |
| 2024-12-11 17:16 | CC:BCT | Briacell Therapeutics Corp (2) | 1.59 | News Release200 | Briacell presents MBC survival data in Spotlight poster |
| 2024-12-02 18:27 | CC:BCT | Briacell Therapeutics Corp (2) | 1.56 | News Release200 | Briacell gets green light from DSMB for phase 3 study |
| 2024-11-26 07:50 | CC:BCT | BRIACELL THERAPEUTICS CORP. J | 0.94 | News Release200 | BriaCell 2024 SABCS(TM) Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer |
| 2024-11-25 16:20 | CC:BCT | Briacell Therapeutics Corp (2) | 0.94 | News Release200 | Briacell director Lustig resigns |
| 2024-11-21 16:05 | CC:BCT | Briacell Therapeutics Corp (2) | 0.85 | News Release200 | Briacell doses first patient in Bria-OTS study |
| 2024-11-08 07:50 | CC:BCT | BRIACELL THERAPEUTICS CORP. J | 0.97 | News Release200 | BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference |
| 2024-11-04 07:50 | CC:BCT | BRIACELL THERAPEUTICS CORP. J | 1.10 | News Release200 | BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium(TM), December 10 - 13 |
| 2024-10-28 15:54 | CC:BCT | Briacell Therapeutics Corp (2) | 1.21 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-10-28 15:53 | CC:BCT | Briacell Therapeutics Corp (2) | 1.21 | SEDAR Annual Report803 | SEDAR Annual Report |
| 2024-10-28 15:48 | CC:BCT | Briacell Therapeutics Corp (2) | 1.21 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-10-22 15:01 | CC:BCT | Briacell Therapeutics Corp (2) | 1.11 | News Release200 | Briacell sees 55% survival rate in one-year patients |
| 2024-10-15 15:20 | CC:BCT | Briacell Therapeutics Corp (2) | 1.34 | News Release200 | Briacell to complete patient enrolment in mid-2025 |
| 2024-10-02 16:43 | CC:BCT | Briacell Therapeutics Corp (2) | 1.33 | News Release200 | Briacell closes $5-million offering |
| 2024-10-01 14:56 | CC:BCT | Briacell Therapeutics Corp (2) | 1.63 | News Release200 | Briacell Therapeutics arranges $5-million offering |
| 2024-10-01 14:49 | CC:BCT | Briacell Therapeutics Corp (2) | 1.63 | News Release200 | Briacell boasts of full resolution in cancer patient |
| 2024-09-18 13:42 | CC:BCT | Briacell Therapeutics Corp (2) | 0.65 | News Release200 | Briacell receives FDA authorization for access policy |
| 2024-09-12 17:04 | CC:BCT | Briacell Therapeutics Corp (2) | 0.84 | News Release200 | Briacell Therapeutics closes $8.5-million financing |
| 2024-09-11 16:13 | CC:BCT | Briacell Therapeutics Corp (2) | 0.84 | News Release200 | Briacell arranges $8.5-million private placement |
| 2024-09-11 14:49 | CC:BCT | Briacell Therapeutics Corp (2) | 0.87 | News Release200 | Briacell boasts of 15.6-month median survival data |
| 2024-09-10 16:11 | CC:BCT | Briacell Therapeutics Corp (2) | 0.90 | News Release200 | Briacell receives feedback over pre-IND meeting |
| 2024-07-18 14:38 | CC:BCT | Briacell Therapeutics Corp (2) | 1.25 | News Release200 | Briacell talks patient survival in Bria-IMT study |
| 2024-06-14 17:13 | CC:BCT | Briacell Therapeutics Corp (2) | 1.89 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-06-14 17:13 | CC:BCT | Briacell Therapeutics Corp (2) | 1.89 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-06-03 12:07 | CC:BCT | Briacell Therapeutics Corp (2) | 2.29 | News Release200 | Briacell Therapeutics presents Bria-IMT clinical data |
| 2024-05-30 09:10 | CC:BCT | Briacell Therapeutics Corp (2) | 2.04 | News Release200 | Briacell begins Bria-OTS breast cancer study enrolment |
| 2024-05-28 10:10 | CC:BCT | Briacell Therapeutics Corp (2) | 1.94 | News Release200 | Briacell to test Bria-OTS with tislelizumab on cancer |
| 2024-05-24 09:54 | CC:BCT | Briacell Therapeutics Corp (2) | 1.98 | News Release200 | Briacell to talk Bria-IMT clinical data at ASCO meeting |
| 2024-05-17 16:45 | CC:BCT | Briacell Therapeutics Corp (2) | 1.87 | News Release200 | Briacell closes $5-million direct offering |
| 2024-05-15 14:07 | CC:BCT | Briacell Therapeutics Corp (2) | 2.30 | News Release200 | Briacell arranges $5-million direct offering |